US Edition
J&J to Invest $1 Billion in New Pennsylvania Plant Amid US ...
J&J plans to create over 500 jobs at its new cell therapy plant, expanding capacity for personalized treatments in a competitive Pennsylvania life sciences market.
- Johnson & Johnson announced Wednesday it will build a next-generation cell therapy plant in Lower Gwynedd, Montgomery County, operated by Janssen Biotech and opening in 2031, creating more than 500 jobs.
- As part of its U.S. plan, Johnson & Johnson said this investment fits its $55 billion U.S. investment plan through early 2029 amid President Donald Trump's tariff threats.
- The Shapiro administration offered $41.5 million in state support, including tax credits, grants and workforce training funds, and the project will create more than 4,000 construction jobs and retain nearly 6,000 Pennsylvania jobs.
- Gov. Josh Shapiro said the investment and aggressive offer convinced Johnson & Johnson to choose Spring House, with local leaders praising it as a major win that cements Pennsylvania's life-sciences role.
- Serving thousands of patients each year, the plant will shorten delivery times and expand capacity for cancer, immune‑mediated and neurological diseases, adding to Eli Lilly & Co.'s $3.5 billion Lehigh Valley plant.
21 Articles
21 Articles
Johnson & Johnson to Invest $1 Billion in New Pennsylvania Cancer Facility
Johnson & Johnson on Feb. 18 announced it would invest more than $1 billion in a next-generation cell therapy manufacturing facility in Montgomery, Pennsylvania, that will create new medicines to treat cancer, and neurological and immune-related diseases. The facility expands upon Johnson & Johnson’s extensive footprint in the Commonwealth of Pennsylvania, where it operates 10 facilities spanning more than 2 million square feet. Johnson & Johnso…
The Reporter
Life sciences firm to invest $1 billion to build Montgomery County plant
LOWER GWYNEDD — Pennsylvania’s life sciences industry in Montgomery County is taking a big step forward. Global health care company Johnson & Johnson announced Wednesday that it will invest $1 billion to build a cell-therapy manufacturing facility at its campus in Lower Gwynedd Township. The facility will be operated by Johnson & Johnson subsidiary Janssen Biotech and will support the production of medicines for cancer, immune mediated and neuro…
'Excellence and hope': Johnson & Johnson building new Pa. facility in fight against cancer
A global health care company says that it will begin making state of the art cancer fighting medicines in our area. It’s a move that Pennsylvania Gov. Josh Shapiro says won’t just save lives but will also create jobs. Johnson & Johnson said it will construct a new facility on Sumneytown Pike in the Spring House section of Lower Gwynedd Township in Montgomery County. They unveiled what the facility will look like when it replaces an existing buil…
The latest generation cell therapy manufacturing unit is part of the company's plans to invest US$ 55 billion in production, research and development and technology in the United States by the beginning of 2029
Coverage Details
Bias Distribution
- 58% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
